These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25747406)

  • 1. Oral films: Current status and future perspectives: I - Galenical development and quality attributes.
    Borges AF; Silva C; Coelho JF; Simões S
    J Control Release; 2015 May; 206():1-19. PubMed ID: 25747406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral films as perspective dosage form].
    Walicová V; Gajdziok J
    Ceska Slov Farm; 2016; 65(1):15-21. PubMed ID: 27118500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films.
    Borges AF; Silva C; Coelho JF; Simões S
    Pharm Dev Technol; 2017 Mar; 22(2):237-245. PubMed ID: 27346557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Success Depends on Your Backbone"-About the Use of Polymers as Essential Materials Forming Orodispersible Films.
    Olechno K; Basa A; Winnicka K
    Materials (Basel); 2021 Aug; 14(17):. PubMed ID: 34500962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
    Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
    Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
    Cilurzo F; Musazzi UM; Franzé S; Selmin F; Minghetti P
    Drug Discov Today; 2018 Feb; 23(2):251-259. PubMed ID: 29030242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive oral films: The potential for unmet needs.
    Silva BM; Borges AF; Silva C; Coelho JF; Simões S
    Int J Pharm; 2015 Oct; 494(1):537-51. PubMed ID: 26315122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orodispersible Films: A Systematic Patent Review.
    Gijare C; Deshpande A
    Recent Pat Drug Deliv Formul; 2018; 12(2):110-120. PubMed ID: 29745346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms.
    Li L; Zhang X; Gu X; Mao S
    Curr Pharm Des; 2015; 21(40):5854-67. PubMed ID: 26446465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent landscape of pediatric-friendly oral dosage forms and administration devices.
    Karavasili C; Gkaragkounis A; Fatouros DG
    Expert Opin Ther Pat; 2021 Jul; 31(7):663-686. PubMed ID: 33605825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orodispersible Films for Compounding Pharmacies.
    Ferreira AO; Brandão MAF; Raposo FJ; Polonini HC; Raposo NRB
    Int J Pharm Compd; 2017; 21(6):454-461. PubMed ID: 29220334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic polymers for orodispersible films: a quality by design approach.
    Borges AF; Silva BM; Silva C; Coelho JF; Simões S
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1357-74. PubMed ID: 27466880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray congealing: a versatile technology for advanced drug-delivery systems.
    Bertoni S; Dolci LS; Albertini B; Passerini N
    Ther Deliv; 2018 Nov; 9(11):833-845. PubMed ID: 30444462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study.
    Visser JC; Wibier L; Mekhaeil M; Woerdenbag HJ; Taxis K
    Int J Clin Pharm; 2020 Apr; 42(2):436-444. PubMed ID: 32052239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.
    Redfearn A; Scarpa M; Orlu M; Hanson B
    J Pharm Sci; 2019 May; 108(5):1831-1836. PubMed ID: 30639737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix systems for oral drug delivery: Formulations and drug release.
    Vasvári G; Kalmár J; Veres P; Vecsernyés M; Bácskay I; Fehér P; Ujhelyi Z; Haimhoffer Á; Rusznyák Á; Fenyvesi F; Váradi J
    Drug Discov Today Technol; 2018 Jul; 27():71-80. PubMed ID: 30103866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the production methods of orodispersible films.
    Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
    Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to assess orodispersible film quality? A review of applied methods and their modifications.
    Wasilewska K; Winnicka K
    Acta Pharm; 2019 Jun; 69(2):155-176. PubMed ID: 31259725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.